Refractory pyoderma gangrenosum associated with rheumatoid arthritis successfully treated with upadacitinib. Comments on: "JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum"
Int J Dermatol
.
2023 Nov;62(11):e595-e598.
doi: 10.1111/ijd.16791.
Epub 2023 Jul 10.
Authors
Mayra Rabelo Dos Santos
1
,
Mayra Ianhez
1
,
Bruno Nazeozeno Ribeiro
2
,
Boaventura Braz de Queiroz
1
,
Helio Amante Miot
3
Affiliations
1
Hospital de Doenças Tropicais Dr Anuar Auad, Goiânia, Goiás, Brazil.
2
Centro Médico Alameda, Goiânia, Goiás, Brazil.
3
Universidade Estadual Paulista Júlio de Mesquita Filho - Campus de Botucatu, Botucatu, São Paulo, Brazil.
PMID:
37424391
DOI:
10.1111/ijd.16791
No abstract available
Publication types
Letter